Return to Clinical Trials Search Results

Intermediate-Size Patient Population Expanded Access of NanoPac® for the Treatment of Pancreatic Cancer

The objective of this expanded access is to provide NanoPac to patients with pancreatic adenocarcinoma who received NanoPac under clinical trial NANOPAC-2016-05 and have completed their participation in the formal clinical trial.

Recruitment Status

Past Studies